Skip to main content
Top

Clinical & Experimental Metastasis

Issue 3/2010

Content (7 Articles)

Research Paper

Tumor-promoting role of signal transducer and activator of transcription (Stat)1 in late-stage melanoma growth

Julia Schultz, Dirk Koczan, Ulf Schmitz, Saleh M. Ibrahim, Dominik Pilch, Jenny Landsberg, Manfred Kunz

Research Paper

Differential changes in platelet VEGF, Tsp, CXCL12, and CXCL4 in patients with metastatic cancer

Tina Wiesner, Stefanie Bugl, Frank Mayer, Jörg T. Hartmann, Hans-Georg Kopp

Research Paper

An orthotopic, postsurgical model of luciferase transfected murine osteosarcoma with spontaneous metastasis

Joseph L. Sottnik, Dawn L. Duval, E. J. Ehrhart, Douglas H. Thamm

Research Paper

Mesenchymal-to-epithelial transition determinants as characteristics of ovarian carcinoma effusions

Sivan Elloul, Olga Vaksman, Helene Tuft Stavnes, Claes G. Trope, Ben Davidson, Reuven Reich

Research Paper

Increased potency of the PHSCN dendrimer as an inhibitor of human prostate cancer cell invasion, extravasation, and lung colony formation

Hongren Yao, Donna M. Veine, Zhao-Zhu Zeng, Kevin S. Fay, Evan D. Staszewski, Donna L. Livant

Research Paper

In vitro metastatic colonization of human ovarian cancer cells to the omentum

Shaheena M. Khan, Holly M. Funk, Sophie Thiolloy, Tamara L. Lotan, Jonathan Hickson, Gail S. Prins, Angela F. Drew, Carrie W. Rinker-Schaeffer

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine